SMMT — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Summit Therapeutics Inc.
Healthcare · $17.31
2.0
/10
Weak Entry
↓ -5.7 today
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
Surface indicators and our internal signals diverge — the score reflects the combined read.
How this score works → Try the calculator ↓
Regime
Bullish
vs SMA200
SMA200 Distance
+5.8%
Above trend
Volatility
Normal
Average premiums
Momentum
Accelerating
was Turning
About Summit Therapeutics Inc.
Summit Therapeutics develops ivonescimab, a bispecific antibody targeting lung cancer. No dividend, high beta, binary Phase 3 catalysts and FDA decision risk. Rich CSP premiums but trial readouts create extreme gap potential. Size positions conservatively and respect event dates.
Biotechnology
Market Cap
$13.8B
P/E Ratio
—
Beta
-1.52
Forward P/E
-15.2
52-Week Range Current: $17.31
$12.07 $29.23
Earnings
2026-10-19
12 days away

SMMT — earnings on 2026-10-19 (12 days) split the expiry calendar. Contracts ending before the report and contracts crossing it carry materially different exposure profiles, even at identical strikes.

Based on end-of-day market dataScored by ThetaLoop Research
SMMT ranks #27 of 66 Healthcare tickers by put-selling score (617 total screened)

Position Size & Yield Calculator

Live model for SMMT — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0 —
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
ELV Elevance Health, Inc. 8.7 JNJ Johnson & Johnson 8.7 REGN Regeneron Pharmaceuticals, Inc. 8.0 CNC Centene Corporation 7.9 MRK Merck & Co., Inc. 7.2 Browse all Healthcare tickers →
📌 Embed this score on your blog
The SMMT X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/SMMT" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/SMMT">SMMT X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Public Trade Ledger — All Recorded Closed Outcomes
Cash-Secured Put ledger ↗ · See a sample →